1. National Institute for Health and Clinical Excellence. Appraising life-extending, end of life treatments. 2009. Available from: http://www.nice.org.uk/media/E4A/79/SupplementaryAdviceTACEoL.pdf. [Accessed May 11, 2013].
2. PHARMAC 2010: guidelines for funding applications to PHARMAC. Available from: http://www.pharmac.govt.nz/2010/02/11/Guidelines%20for%20Suppliers%20Submissions.pdf. [Accessed May 11, 2013].
3. Helsedirektoratet. Samfunnsøkonomiske analyser i helsesektoren – en veileder. (2011) IS-1915.
4. Brouwer WBF. Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall;van de Wetering;Eur J Health Econ,2013
5. Dolan P, Edlin R, Tsuchiya A, et al. The relative societal value of health gains to different beneficiaries. Health Technology Assessment Programme Journal Series Report RM03/JH11/PD, University of Birmingham, 2008.